Staley Capital Advisers Inc. Sells 7,070 Shares of Corteva, Inc. $CTVA

Staley Capital Advisers Inc. decreased its stake in shares of Corteva, Inc. (NYSE:CTVA) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 536,078 shares of the company’s stock after selling 7,070 shares during the quarter. Corteva comprises about 1.5% of Staley Capital Advisers Inc.’s portfolio, making the stock its 21st largest holding. Staley Capital Advisers Inc. owned approximately 0.08% of Corteva worth $36,255,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Norges Bank bought a new position in shares of Corteva during the 2nd quarter valued at about $434,220,000. Pacer Advisors Inc. boosted its stake in Corteva by 4,007.1% during the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after buying an additional 2,382,715 shares during the last quarter. Marshall Wace LLP grew its holdings in Corteva by 1,365.9% during the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock valued at $134,882,000 after buying an additional 1,686,309 shares in the last quarter. National Pension Service increased its stake in Corteva by 148.4% in the 2nd quarter. National Pension Service now owns 2,454,601 shares of the company’s stock worth $182,941,000 after acquiring an additional 1,466,268 shares during the last quarter. Finally, Qube Research & Technologies Ltd boosted its position in shares of Corteva by 566.0% during the 2nd quarter. Qube Research & Technologies Ltd now owns 1,247,120 shares of the company’s stock valued at $92,948,000 after acquiring an additional 1,059,872 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. CICC Research boosted their price target on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 11th. The Goldman Sachs Group restated a “buy” rating and issued a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and increased their price target for the company from $75.00 to $77.00 in a report on Thursday, February 5th. UBS Group cut Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Finally, Bank of America raised their price objective on Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $82.30.

Corteva Price Performance

Shares of CTVA stock opened at $80.01 on Monday. The stock has a 50 day moving average price of $71.91 and a 200 day moving average price of $68.79. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.23. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The firm has a market capitalization of $53.81 billion, a P/E ratio of 50.64, a P/E/G ratio of 2.74 and a beta of 0.72.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue was down 1.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.15% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.